Clinical Applications of Nuclear Medicine Targeted Therapy
This book offers a practical and modern update on radioisotope therapy. Clinically oriented, it provides a thorough guide to patient management, with the latest indications and procedures for the current radioisotopic treatments. It addresses the clinical
- PDF / 13,951,386 Bytes
- 488 Pages / 504.63 x 737.01 pts Page_size
- 74 Downloads / 195 Views
123 123
Clinical Applications of Nuclear Medicine Targeted Therapy
Emilio Bombardieri Ettore Seregni Laura Evangelista Carlo Chiesa Arturo Chiti Editors
Clinical Applications of Nuclear Medicine Targeted Therapy
Editors Emilio Bombardieri Department of Nuclear Medicine Humanitas Gavazzeni Hospital Bergamo Italy Laura Evangelista Nuclear Medicine and Molecular Imaging Unit Veneto Institute of Oncology IOV - IRCCS Padova Italy
Ettore Seregni Nuclear Medicine Therapy and Endocrinology Istituto Nazionale dei Tumori Milano Italy Carlo Chiesa Nuclear Medicine Division Istituto Nazionale dei Tumori Milano Italy
Arturo Chiti Nuclear Medicine Humanitas Research Hospital Rozzano Milano Italy
ISBN 978-3-319-63066-3 ISBN 978-3-319-63067-0 (eBook) https://doi.org/10.1007/978-3-319-63067-0 Library of Congress Control Number: 2017964315 © Springer International Publishing AG, part of Springer Nature 2018 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. The publisher remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Printed on acid-free paper This Springer imprint is published by the registered company Springer International Publishing AG part of Springer Nature The registered company address is: Gewerbestrasse 11, 6330 Cham, Switzerland
Foreword
For many decades, nuclear medicine targeted therapy or targeted systemic radiotherapy has been one of the cornerstones of Nuclear Medicine, exploiting the synergy between molecular imaging and the subsequent treatment of patients. This so called theranostic approach capitalizes the unique opportunities provided by pretreatment molecular imaging to determine the targeting of areas of interest (tumors, hyperfunctioning thyroid, etc.) and to assess the pharmacokinetics and biodistribution of radiopharmaceuticals. Thus, nuclear medicine therapy is a perfect example of individualized, precision medicine. Before exposing the patient to a therapeutic radiopharmaceutical, the disease and d
Data Loading...
